Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

OncoAlert and ecancer weekly roundup for October 12 - 18, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 12 - 18, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
23 Oct 2020

OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
12 Oct 2020

Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer

Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Oct 2020

OncoAlert and ecancer weekly roundup for September 27 - October 4th, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 27 - October 4th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
6 Oct 2020

Lenalidomide combination for multiple myeloma

Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France
Lenalidomide combination for multiple myeloma ( Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France )
1 Oct 2020

OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer

Prof Fabrice André - Institut Gustave Roussy, Paris, France
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
29 Sep 2020

PROFound trial and other recent updates in prostate cancer

Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
PROFound trial and other recent updates in prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Sep 2020

ESMO 2020 renal roundup

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ESMO 2020 renal roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
25 Sep 2020

Exon 20 insertions in NSCLC - ESMO 2020

Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro
Exon 20 insertions in NSCLC - ESMO 2020 ( Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro )
25 Sep 2020

ESMO 2020: Lung cancer latest

Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay Popat
ESMO 2020: Lung cancer latest ( Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay Popat )
25 Sep 2020

Highlights from ESMO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ESMO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Sep 2020

PARP inhibitors and their evolving role for the treatment of prostate cancer

Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
PARP inhibitors and their evolving role for the treatment of prostate cancer ( Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi )
24 Sep 2020